TMOD1: A Protein Involved in Cancer Development and Drug Targets

Target Name: TMOD1

NCBI ID: G7111

TMOD1

TMOD1: A Protein Involved in Cancer Development and Drug Targets

TMOD1 (Tumor Model of the Day 1) is a protein that is expressed in various tissues of the body, including the brain, and has been identified as a potential drug target for various diseases, including cancer. The protein is involved in a variety of cellular processes, including cell signaling, and has been shown to play a role in the development and progression of cancer.

TMOD1 is a member of the superfamily of transmembrane protein (SMP), which are a type of protein that spans the membrane of the cell and extend into the cytoplasm. SMPs are involved in a variety of cellular processes, including cell signaling, and are often involved in the development and progression of cancer.

TMOD1 is expressed in a variety of tissues and organs, including the brain, heart, and liver. It has been shown to be involved in a variety of cellular processes, including cell signaling, cell migration, and the regulation of ion channels. TMOD1 has also been shown to play a role in the development and progression of cancer, and is often used as a drug target for various diseases, including cancer.

TMOD1 has been shown to be involved in a variety of signaling pathways, including the TGF-β pathway, which is involved in cell signaling and is often involved in the development and progression of cancer. The TGF-β pathway is a complex signaling pathway that is involved in the regulation of cellular processes, including cell growth, differentiation, and the regulation of ion channels. TMOD1 has been shown to be involved in the regulation of TGF-β signaling, and has been shown to play a role in the development and progression of cancer.

TMOD1 has also been shown to be involved in the regulation of cell migration, which is the process by which cells move from one location to another in the body. Cell migration is a critical process that is involved in the development and progression of cancer, and is often disrupted in cancer cells. TMOD1 has been shown to be involved in the regulation of cell migration, and has been shown to play a role in the development and progression of cancer.

TMOD1 has also been shown to be involved in the regulation of ion channels, which are responsible for the flow of electrical current through the cell membrane. Ion channels are critical for the regulation of a variety of cellular processes, including cell signaling and the regulation of cell temperature. TMOD1 has been shown to be involved in the regulation of ion channels, and has been shown to play a role in the development and progression of cancer.

In conclusion, TMOD1 is a protein that is involved in a variety of cellular processes, including cell signaling, cell migration, and the regulation of ion channels. TMOD1 has been shown to play a role in the development and progression of cancer, and is often used as a drug target for various diseases, including cancer. Further research is needed to fully understand the role of TMOD1 in cellular processes and its potential as a drug target.

Protein Name: Tropomodulin 1

Functions: Blocks the elongation and depolymerization of the actin filaments at the pointed end. The Tmod/TM complex contributes to the formation of the short actin protofilament, which in turn defines the geometry of the membrane skeleton. May play an important role in regulating the organization of actin filaments by preferentially binding to a specific tropomyosin isoform at its N-terminus

The "TMOD1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMOD1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets